Mark Dahlin

CMC Senior Project Manager at Blueprint Medicines - Cambridge, MA, US

Mark Dahlin's Colleagues at Blueprint Medicines
Glenn Nugent

Area Business Manager

Contact Glenn Nugent

Marcie Reeder

Director, Global Patient Affairs

Contact Marcie Reeder

Mike Durkin

Regional Director, Medical Science Liaisons

Contact Mike Durkin

Meghan Clark

Area Business Manager

Contact Meghan Clark

Charlie Rowland

Board and Compensation Committee Member and Chair of Audit Committee

Contact Charlie Rowland

Alison Nagle

Medical Science Liaison - Associate Director

Contact Alison Nagle

View All Mark Dahlin's Colleagues
Mark Dahlin's Contact Details
HQ
617-374-7580
Location
United States
Company
Blueprint Medicines
Mark Dahlin's Company Details
Blueprint Medicines logo, Blueprint Medicines contact details

Blueprint Medicines

Cambridge, MA, US • 500 - 999 Employees
BioTech/Drugs

Blueprint Medicines develops kinase inhibitors for genomically defined cancer subsets of precision therapies, designed to allow patients to live longer and healthier lives.

Oncology drug discovery Oncology Genomically defined diseases Rare diseases Transformative drugs Robust drug pipeline Systemic mastocytosis Hepatocellular carcinoma Orphan drugs Small molecules Kinase inhibitor Personalized medicine Novel cancer therapies B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about Blueprint Medicines
Frequently Asked Questions about Mark Dahlin
Mark Dahlin currently works for Blueprint Medicines.
Mark Dahlin's role at Blueprint Medicines is CMC Senior Project Manager.
Mark Dahlin's email address is ***@blueprintmedicines.com. To view Mark Dahlin's full email address, please signup to ConnectPlex.
Mark Dahlin works in the BioTech/Drugs industry.
Mark Dahlin's colleagues at Blueprint Medicines are Lara Robinson, Glenn Nugent, Marcie Reeder, Mike Durkin, Meghan Clark, Charlie Rowland, Alison Nagle and others.
Mark Dahlin's phone number is 617-374-7580
See more information about Mark Dahlin